Gastrointestinal side effects are the most frequently reported and include nausea, vomiting, diarrhoea, constipation, and abdominal discomfort
This may improve adherence, reduce treatment fatigue, and help integrate chronic obesity management more seamlessly into a patient's daily life, much like taking a daily pill for hypertension or dyslipidemia
The role of NLRP3 inflammasome in infection-related, immune-mediated and autoimmune skin diseases
Many people find that side effects especially nausea are most noticeable early in treatment or after a dose step-up, and ease as the body adjusts
This is the most practical difference right now, and for many people, the only one that matters today